科笛－Ｂ 02487 Prospectus Information

IPO Timeline

Broker Results (T-2)

2023-06-08

Some brokers release in afternoon

Grey Market (T-1)

2023-06-09

Afternoon

HKEX Allotment (T-1)

2023-06-09

Evening

Registrar Allotment (T-1)

2023-06-09

Evening

Listing Day (T)

2023-06-12

First day of trading

Company Overview

Stock Name	科笛－Ｂ
Stock Code	02487
Company Full Name	科笛－Ｂ
Industry	醫療保健
Principal Activities	公司是一家專注于皮膚學的研發型生物制藥公司，致力于開發全面的解決方案，以滿足患者及消費者在廣泛皮膚病治療及護理市場中不斷變化的多樣化需求。
Listing Date	2023-06-12
Listing Rules Era	Old Rules
Listing Rules Chapter	To be extracted
Weighted Voting Rights (WVR)	No
Registered Address (Mainland China)	中國上海市靜安區恒豐路436號環智國際大廈20樓
Business Address (Hong Kong)	To be extracted
Place of Incorporation	To be extracted
Listing Method	To be extracted
Listing Board	Main Board
Website	https://www.cutiatx.com
Share Registrar	卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact	(852)2980 1333
A-Share/US Dual Listing	No data

Offering Information

Offering Mechanism	To be extracted
Offer Price	HK$ 21.85 / shares
Offer Price Range	To be extracted
Lot Size	To be extracted
Entry Threshold	To be extracted
Par Value	To be extracted
Offer Period	To be extracted
Global Offering Shares	To be extracted
HK Public Offer Shares (Initial)	To be extracted
Public Offer Lots (Initial)	To be extracted
International Placing Shares (Initial)	To be extracted
Offer Ratio	To be extracted
Total Shares Post-IPO	To be extracted
Greenshoe (Over-allotment Option)	To be confirmed
Stabilizing Manager (Greenshoe)	—
Cornerstone Share	39.0%
Clawback Tiers	To be extracted
Reallocation Option	To be confirmed
Total Global Offering Size	HK$ 46,505,540

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A

Lots Subscribed	Shares Subscribed	Subscription Amount (HKD)
1 lots	200	HK$ 4,370
2 lots	400	HK$ 8,740
3 lots	600	HK$ 13,110
4 lots	800	HK$ 17,480
5 lots	1,000	HK$ 21,850
6 lots	1,200	HK$ 26,220
7 lots	1,400	HK$ 30,590
8 lots	1,600	HK$ 34,960
9 lots	1,800	HK$ 39,330
10 lots	2,000	HK$ 43,700
15 lots	3,000	HK$ 65,550
20 lots	4,000	HK$ 87,400
25 lots	5,000	HK$ 109,250
30 lots	6,000	HK$ 131,100
35 lots	7,000	HK$ 152,950
40 lots	8,000	HK$ 174,800
45 lots	9,000	HK$ 196,650
50 lots	10,000	HK$ 218,500
100 lots	20,000	HK$ 437,000
150 lots	30,000	HK$ 655,500
250 lots	50,000	HK$ 1,092,500

Pool B

Lots Subscribed	Shares Subscribed	Subscription Amount (HKD)
5,321 lots	1,064,200	HK$ 23,252,770

Valuation & Financials

Market Cap (at Offer Price)	To be extracted
Pre-IPO Valuation (Last Round)	To be extracted
P/E Ratio	To be extracted
Profit/Loss Status	To be extracted
Period-End Cash Balance	To be extracted
Listing Expenses	To be extracted
Listing Expenses / Funds Raised	To be extracted
Total Pre-IPO Investment	To be extracted

First Day Performance

First Day Close	HK$ 21.95
First Day Open	HK$ 21.8
First Day Change	-79.95%
First Day Volume	1319600.0
First Day Turnover	28628000.0

Use of Proceeds

Use of Proceeds	1、約176.7百萬港元（即所得款項凈額的45.0%）將用于我們的核心產品CU-20401； 2、約86.4百萬港元（即所得款項凈額的22.0%）將用于撥付我們主要產品CU-40102及CU-10201的持續研發活動； 3、約70.7百萬港元（即所得款項凈額的18.0%）將用于撥付我們管線中其他候選產品的持續研發活動； 4、約39.3百萬港元（即所得款項凈額的10.0%）乃用于管線擴展的技術開發及業務開發； 5、約19.6百萬港元（即所得款項凈額的5.0%）將用作營運資金及其他一般企業用途。

1、約176.7百萬港元（即所得款項凈額的45.0%）將用于我們的核心產品CU-20401； 2、約86.4百萬港元（即所得款項凈額的22.0%）將用于撥付我們主要產品CU-40102及CU-10201的持續研發活動； 3、約70.7百萬港元（即所得款項凈額的18.0%）將用于撥付我們管線中其他候選產品的持續研發活動； 4、約39.3百萬港元（即所得款項凈額的10.0%）乃用于管線擴展的技術開發及業務開發； 5、約19.6百萬港元（即所得款項凈額的5.0%）將用作營運資金及其他一般企業用途。

Underwriting Syndicate

Sole Sponsor (1)

中国国际金融香港证券有限公司 CE AEN894

Overall Coordinators (5)

中国国际金融香港证券有限公司 CE AEN894 德意志银行香港分行中信里昂证券有限公司 CE AAB893 华泰金融控股（香港）有限公司 CE AOK809 招银国际融资有限公司 CE AVM940

Joint Bookrunners (9)

中国国际金融香港证券有限公司 CE AEN894 德意志银行香港分行中信里昂证券有限公司 CE AAB893 华泰金融控股（香港）有限公司 CE AOK809 招银国际融资有限公司 CE AVM940 中银国际亚洲有限公司 CE AET863 大华继显（香港）有限公司 CE AAW261 富途证券国际（香港）有限公司 CE AZT137 华盛资本证券有限公司 CE AUL711

Joint Lead Managers (11)

Cornerstone Investors

#	Investor Name	Investment Amount	Shares Subscribed	% of Offer Shares	% of Total Shares	Lock-up Period	Est. Unlock Date
1	Harvest International Premium Value (Secondary Market) Fund SPC	156,415,410 HKD	—	33.64%	—	6 months	2023-12-12
2	So-Young Hong Kong Limited	7,817,930 HKD	—	1.68%	—	6 months	2023-12-12
3	无锡新鸿笛创业投资合伙企业(有限合伙)	17,204,690 HKD	—	3.70%	—	6 months	2023-12-12

Directors & Management

Chairman	陳連勇
Company Secretary	梁志杰

No director data available.

Major Shareholders

Major Shareholders & Holdings	通和毓承實體(49.82%);YF Dermatology Limited(13.16%);SCC Growth V 2020-C, L.P.(11.28%);Fidelity(7.47%)

Subscription Tiers

IPO Timeline

科笛－Ｂ 02487Prospectus Information